Enya Scanlon

Enya Scanlon is a Research Fellow at Queen's University Belfast, affiliated with the School of Medicine, Dentistry and Biomedical Sciences and the Patrick G Johnston Centre for Cancer Research. Her work focuses on cancer research, with a particular emphasis on therapeutic target identification, immune microenvironment modulation, and drug repositioning strategies. She holds a Doctor of Philosophy (2023) from Queen's University, supervised by Prof. R. Kennedy and Prof. J. Blayney.

Her research contributes to UN Sustainable Development Goals related to good health and well-being. Key interests include colorectal cancer, esophageal adenocarcinoma, and the application of bioinformatics for patient stratification and biomarker development.

Scanlon has collaborated on clinical trials (e.g., DEBIOC) and functional genomic studies, exploring Src kinase's role in chemotherapy resistance. Her work bridges basic science and translational research, with publications in journals like ESMO Open and Cancers.

Notable contributions include in silico drug repositioning methodologies and the identification of IBD-like subgroups in colorectal cancer patients. Her research aims to improve therapeutic strategies and patient outcomes through precision medicine approaches.